ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 186 filers reported holding ACHILLION PHARMACEUTICALS IN in Q4 2014. The put-call ratio across all filers is 0.38 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $64,000 | -63.4% | 10,640 | -82.0% | 0.00% | – |
| Q1 2019 | $175,000 | +86.2% | 59,210 | 0.0% | 0.00% | – |
| Q4 2018 | $94,000 | -56.9% | 59,210 | 0.0% | 0.00% | – |
| Q3 2018 | $218,000 | +29.8% | 59,210 | 0.0% | 0.00% | – |
| Q2 2018 | $168,000 | -24.0% | 59,210 | -0.3% | 0.00% | – |
| Q1 2018 | $221,000 | +30.0% | 59,410 | +0.4% | 0.00% | – |
| Q4 2017 | $170,000 | -89.3% | 59,200 | -63.1% | 0.00% | -100.0% |
| Q1 2015 | $1,585,000 | -46.7% | 160,635 | -33.7% | 0.00% | -50.0% |
| Q4 2014 | $2,971,000 | +179.0% | 242,415 | +127.1% | 0.00% | +100.0% |
| Q3 2014 | $1,065,000 | +106400.0% | 106,728 | +71052.0% | 0.00% | – |
| Q2 2014 | $1,000 | -99.8% | 150 | -99.9% | 0.00% | – |
| Q3 2013 | $528,000 | -59.1% | 175,009 | +10.9% | 0.00% | -100.0% |
| Q2 2013 | $1,291,000 | – | 157,869 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 13,633,220 | $56,305,000 | 7.98% |
| BVF INC/IL | 2,423,300 | $10,008,000 | 2.01% |
| EMORY UNIVERSITY | 454,102 | $1,875,000 | 1.85% |
| DAFNA Capital Management LLC | 196,500 | $812,000 | 0.71% |
| Orbimed Advisors | 13,107,200 | $54,133,000 | 0.69% |
| RTW INVESTMENTS, LP | 286,285 | $1,182,000 | 0.44% |
| Marcus Capital, LLC | 100,000 | $413,000 | 0.44% |
| Rock Springs Capital Management LP | 1,375,000 | $5,679,000 | 0.38% |
| Spark Investment Management LLC | 978,600 | $4,041,000 | 0.33% |
| Bellevue Group AG | 240,000 | $991,000 | 0.20% |